Archive for November, 2019

$LXRP Oregon Senators Object to USDA Hemp Testing Rules

November 27, 2019

Few industries can claim to have experienced the same explosion of growth the hemp sector has enjoyed. Valued at $4.4 billion in 2018, the industry is expected to be worth a whopping $14.67 billion by 2026. While these figures paint an awesome picture, the hemp sector didn’t have the time to grow organically with comprehensive regulations already in place.

The USDA has had to play catch up, releasing its interim final rule on hemp a year after the 2018 Farm Bill legalized the cultivation of industrial hemp. While industry stakeholders are glad the industry now has structure, the restrictive nature of the proposed rules has been called into question.

According to two senators who’ve been key supporters of the budding hemp industry, the proposed federal plan to test for THC will damage the industry. The USDA hemp production rules, say, Senators Jeff Merkley and Ron Wyden, lay out testing requirements with “potentially harmful effects for the new hemp industry.”

Last week on Tuesday, the two Senators sent a letter to Agriculture Secretary Sonny Perdue requesting changes to the draft rules published last month. The letter stated that while the USDA’s proposed regulations were a necessary step to establish a domestic federal hemp production program, they wanted to highlight “several concerns about the unintended and potentially harmful effects this interim rule would have on hemp production in Oregon and across the country.”

According to the new draft rules, hemp has to be tested within 15 days before harvest. Farmers have argued that this is too little time, and the letter calls for the USDA to extend the testing period to 28 days. Farmers would also be required to test their crops in labs that have been registered with the Drug Enforcement Administration. The senators say this will result in bottlenecks and delays for hemp producers. They ask the USDA to allow farmers to use labs not registered with the DEA as long as those labs have been approved by the state.

The proposed rules also require the testing to be carried out after decarboxylation. The letter urges the USDA to allow THC testing to be done before decarboxylation and to limit the screening to just delta-9 THC instead of all THC compounds.

Another topic the letter addresses is allowable THC levels. The proposal sets the limit at 0.5%, but the senators hope the USDA will raise it to 1%. They also challenged the need to test samples from the top third of the plant, asking the USDA to limit the screening to the top 8 inches of the plant.

They add that the farmers in Oregon and across the country are on the precipice of an agricultural boom that “with the right regulatory framework, stands to boost rural economies in every corner of the country.”

Analysts believe these sentiments about the proposed testing requirements may also be shared by other key hemp industry players like SinglePoint Inc. (OTCQB: SING) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

Wednesday, November 27th, 2019 Uncategorized Comments Off on $LXRP Oregon Senators Object to USDA Hemp Testing Rules

$TGODF $TGOD 420 with CNW – 5 Banking Options Marijuana Companies Can Explore

November 27, 2019

Every month, many marijuana companies across the U.S. have to move physical cash from their premises in order to pay for utilities and other needed supplies and this is a common practice among marijuana businesses. Although marijuana is legal in most states in the U.S., banks that are federally insured have prohibited the opening of accounts for cannabis businesses. This is because they are afraid of being accused of criminal activity since federally, marijuana is a controlled substance under Schedule 1 of the Controlled Substances Act.

The refusal of banks to conduct business with weed businesses has left them with no alternative but to operate on a cash basis. For example, NUG is licensed to cultivate and manufacture marijuana products in its facilities in California, and since it cannot deposit the money in the banks, the only way to safeguard it is to keep it in locked vaults.

The founder and CEO of NUG, John Oram, said that the company headquarters is set up like a casino as it has vaults and electric notes counters. He also noted that a minimum of two employees must be present when a transaction is taking place. Oram further said that the company hired armed guards for cash deliveries from the dispensaries and the guards are also cautioned to switch up their routes to avoid predictability.  NUG has 200 employees who are paid in cash. Taxes are also paid in cash.

Oram is hoping to start working with Pacific Banking Corporation to alleviate transacting on a cash basis. Some of the methods marijuana business could use to avoid operating on a cash-only basis include:

PayQwick

PayQwick was formed by two attorneys, and it functions like PayPal. Businesses and customers deposit money into a system that allows them to transact back and forth. It also permits money transfers to and from banks. Farmers can use the app to pay for seeds and soils, while customers can pay for products at the dispensary. The app allows the transfer of money across state lines and takes on the responsibility of federal compliance, such as due diligence and compilation of suspicious activity reports.

CanPay

CanPay is a mobile debit app that is widely used by marijuana retailers and businesses. Customers do not pay extra fees upon making a purchase, and customers can only transact at a maximum of $250 per day. Every time a purchase is made, the same amount is debited in your checking account. Currently, 400 medical and recreational marijuana businesses are transacting using the app.

Hypur

Hypur provides banking institutions with a legitimate way of transacting with highly regulated industries, such as the marijuana industry, through an electronic app. Hypur matches cannabis businesses with banks or credit unions since it has every detail about the financial institutions.

Dama Financial

Dama Financial has a network of all banks that are insured by the FDIC that are interested in transacting with marijuana businesses. The business looking to work with the bank must fill in an online application and agree to an on-site inspection. Once approved, Dama manages the company’s banking services, and this includes transportation of cash to the processing facility and receiving the deposits via ACH wire. The money is deposited in the company’s account the following day.

Local Banks and Credit Unions

Some small banks are open to conducting business with well-organized weed businesses, although many are still wary of marijuana businesses. You can therefore do your homework and find one of these small institutions that can accept your cannabis business as a client.

These options should ease the pressure on marijuana entities like The Green organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Green Hygienics Holdings Inc. (OTCQB: GRYN) who may need backup arrangements in case banks pull the plug on them.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Wednesday, November 27th, 2019 Uncategorized Comments Off on $TGODF $TGOD 420 with CNW – 5 Banking Options Marijuana Companies Can Explore

$TGODF Announces $22.0 Million Bought Deal Public Offering Plus Over-Allotment Option

Canada NewsWire

TORONTO, Nov. 26, 2019

TORONTO, Nov. 26, 2019 – The Green Organic Dutchman Holdings Ltd.  (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. (the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a short form prospectus, an aggregate of 29,334,000 units (the “Units”) at a price of $0.75 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of approximately C$22.0 million (the “Offering”).

Each Unit shall consist of one common share (each a “Common Share”) and one-half of one common share purchase warrant of the Company (each whole such warrant, a “Warrant”). Each Warrant shall be exercisable to acquire one common share of the Company for a period of 36 months from closing of the transaction at an exercise price of C$1.00 per Warrant.

The Company has granted the Underwriter an option (the “Over-Allotment Option”) to purchase up to an additional 4,400,100 Units at a price of C$0.75 per Unit, exercisable at any time, for a period of 30 days after and including the Closing Date, which, if exercised, would result in additional proceeds of up to approximately $3.3 million. The Over-Allotment Option is exercisable to acquire Units, Common Shares and/or Warrants (or any combination thereof) at the discretion of the Underwriters.

The Units will be offered by way of a short form prospectus to be filed in all provinces of Canada except Quebec. The Offering is expected to close on December 17, 2019 and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX and the applicable securities regulatory authorities.

The Company will use best efforts to obtain the necessary approvals to list the Common Shares and the Common Shares issuable upon exercise of the Warrants on the Toronto Stock Exchange (“TSX”).

The Offering provides the Company with more capital advanced on closing and is less dilutive than the previously announced convertible note term sheet, which was structured with a series of conditional tranches and is no longer being pursued by the Company. The company continues towards finalizing the mortgage loan arrangement and the sale and leaseback of the energy centre at its Ancaster facility that were also previously announced.

TGOD intends to use the proceeds of the Offering to complete construction of its processing facility at Ancaster and for general corporate purposes.

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US‐OTC: TGODF) is a premium certified organic cannabis company focused on the health and wellness market.  Its certified‐organic cannabis is grown in living soil, as nature intended.  The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities are being built to LEED certification standards and its products are sold in recyclable packaging.  In Canada, TGOD plans to expand its product portfolio by launching a series of next‐generation cannabis products such as organic teas, infusers and vapes.  Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Cautionary Statements

This news release includes statements containing certain “forward‐looking information” within the meaning of applicable securities law (“forward‐looking statements”). Forward looking statements in this release includes, but is not limited to, statements about timing or likelihood of closing of financings, statement about the availability of future financing tranches, statement about potential to receive regulatory approvals, statement about the offering of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company.  Forward‐looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “should”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions.  Various assumptions were used in drawing the conclusions or making the projections contained in the forward‐looking statements throughout this news release. Forward‐looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties (including market conditions) and other factors that could cause actual events or results to differ materially from those projected in the forward‐looking statements, including those risk factors described in the Company’s most recently filed Annual Information Form available on SEDAR.  The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward‐looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither the TSX nor the TSX’s Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

Tuesday, November 26th, 2019 Uncategorized Comments Off on $TGODF Announces $22.0 Million Bought Deal Public Offering Plus Over-Allotment Option

$SRAX Enables Consumers to Own, Manage, Sell Data via BIGtoken Platform

SRAX (NASDAQ: SRAX), a digital-marketing and consumer-data-management technology platform company, provides a secure and transparent environment for consumers to own, manage, and sell access to their digital identity and data through its proprietary BIGtoken platform. An article discussing the company reads, “Through BIGtoken, SRAX has created a symbiotic relationship between big brands desiring to know their consumers better and the consumers themselves who want to remain in control of their data at ever-increasing rates. In exchange for giving brands access to their data by answering surveys, checking into locations, referring friends and more, BIGtoken users are rewarded with points, which they can then redeem for cash and gift cards or make charitable donations. SRAX’s technology then unlocks data to reveal the core consumers of brands across marketing channels. As one of the first companies to offer consumers a significant piece of the data pie, SRAX is building the largest and most valuable opted-in data set in the world.”

To view the full article, visit http://nnw.fm/mF9TT

About SRAX Inc.

SRAX (NASDAQ: SRAX) is a digital-marketing and consumer-data-management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and the characteristics of those consumers across marketing channels. Monetizing its data sets, SRAX is growing multiple, recurring revenue streams through its various platforms. Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby offering everyone in the internet ecosystem choice, transparency and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Tuesday, November 26th, 2019 Uncategorized Comments Off on $SRAX Enables Consumers to Own, Manage, Sell Data via BIGtoken Platform

$OGI Air Force Tells Airmen to Stay Away From CBD Products

November 26, 2019

Cannabidiol (CBD) has been having an amazing run over the past few years. For an ingredient that was almost unknown a decade ago, CBD has quickly captured the minds and hearts of people around the globe. Said to have potent medicinal properties, the cannabis extract is used to manage a variety of conditions ranging from anxiety and high blood pressure to chronic pain.

However, despite the immense popularity cannabidiol has garnered, the industry is still heavily unregulated. Without a comprehensive regulatory structure, the market has been flooded with a plethora of sellers, each selling products promising untold medical benefits. Due to this, numerous institutions have shied away from using CBD, and the U.S. Air Force is the latest to register their disapproval for CBD products.

On Tuesday, the service issued a notice to its Airmen stating that products containing CBD oil are off-limits. Products with CBD oil will lead to positive results for Airmen undergoing urinalysis to detect marijuana. Article 112a of the Uniform Code of Military Justice prohibits service members from using marijuana, and those who do will be subject to punishment.

“It’s important for both uniformed and civilian Airmen to understand the risk these products pose to their careers,” says Major Jason Gammons, Air Force Office of the Judge Advocate General spokesman. “Products containing unregulated levels of THC can cause positive drug tests, resulting in the same disciplinary actions as if members had consumed marijuana.”

One issue that has plagued the CBD industry is quality control. According to the 2018 Farm Bill, for cannabis to be classified as legal industrial hemp, it has to have less than 0.3% THC (tetrahydrocannabinol). THC is the component responsible for the psychotropic high that cannabis is famous for. However, the industry is flooded with CBD products that have more than the legally mandated level of THC.

The Air Force cited a 2017 report by Marcel O. Bonn-Miller from the University of Pennsylvania, Perelman School of Medicine that examined 84 CBD products sold online. The report stated that less than a third of the products actually contained the required CBD levels while 21% of the products had more than the minimum 0.3% THC required by the Farm Bill.

“The important thing for Airmen to consider is the level of uncertainty for these products. We want to ensure we arm them with the facts so they can make informed decisions and not jeopardize their military careers.”

Airmen who test positive for marijuana during urinalysis typically receive a discharge and an Article 15 sanction, which is the highest form of military non-judicial punishment.

CBD industry experts are of the view that industry actors like Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) and The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) could be disappointed by the announcement of the Air Force, but they understand that the institution has to take precautions to safeguard its personnel from some products that may have contents that differ from what is on the label.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Tuesday, November 26th, 2019 Uncategorized Comments Off on $OGI Air Force Tells Airmen to Stay Away From CBD Products

$LXRP Set to Profit from FDA’s MRTP Pathway Announcement

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, is positioned to benefit from the FDA’s recent announcement that it had authorized the marketing of eight smokeless tobacco products through the modified-risk, tobacco-product (“MRTP”) pathway (http://cnw.fm/PaC87). An article discussing the company reads, “The FDA approval of the ‘modified risk’ claims was made after reviewing scientific evidence submitted by the manufacturer of the products. The approvals, which are product specific and expire after five years, do not mean the products come with no health risks. Nicotine-based products are addictive and may, according to some studies, induce the onset of cardiovascular, respiratory and gastrointestinal disorders. . . . The patented DehydraTECH(TM) drug-delivery platform mitigates a serious limitation to nicotine ingestion. The human GI system struggles to process nicotine in the forms in which it is presently offered, one reason why there are currently no edible, nicotine, manufactured products available, although some natural foods — eggplant, green pepper, potato, tomato — do contain nicotine. However, DehydraTECH employs a delivery mechanism that improves the bioabsorption and bioavailability of many ingestible substances, as well as their taste and smell, by using lipophilic agents. Application of the technology extends beyond nicotine to nonpsychoactive cannabinoids, vitamins and nonsteroidal anti-inflammatory drugs (NSAIDs).”

To view the full article, visit http://cnw.fm/zZmw5

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Tuesday, November 26th, 2019 Uncategorized Comments Off on $LXRP Set to Profit from FDA’s MRTP Pathway Announcement

$CNPOF $RIV.V Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the expansion of its strategic advisory board to add Thirty Five Ventures, the business owned by NBA star Kevin Durant and sports business executive Rich Kleiman. According to the update, Thirty Five Ventures will collaborate with Canopy Rivers as it continues to pursue its global growth strategy and strengthen its global portfolio of leading cannabis companies. Canopy Rivers will also look to co-invest with Thirty Five Ventures on cannabis-related deals, leveraging the group’s expertise in brand development and marketing. “We’re thrilled to have Thirty Five Ventures join the Canopy Rivers team,” Narbé Alexandrian, president and CEO of Canopy Rivers, said in the news release. “Kevin Durant and Rich Kleiman have built an incredible brand worldwide, investing in and growing some of the cannabis and tech industry’s hottest companies. We’re excited to combine our venture capital knowledge and cannabis domain expertise, and we believe that this partnership will drive success for our portfolio as we continue to grow it in the years ahead.”

To view the full press release, visit http://cnw.fm/pw4Lf

About Canopy Rivers Inc.

Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://cnw.fm/CNPOF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Tuesday, November 26th, 2019 Uncategorized Comments Off on $CNPOF $RIV.V Bolsters its Strategic Advisory Board with Kevin Durant’s Thirty Five Ventures

$SGLB CEO to Present at the 12th Annual LD Micro Main Event

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been invited to present at the 12th Annual LD Micro Main Event. The event is slated to take place at the Luxe Sunset Boulevard Hotel in Los Angeles, California on December 10-12, 2019. According to the update, Sigma Labs CEO John Rice will host one-on-one meetings throughout the day and is scheduled to present at 3:20 p.m. Pacific Time on Tuesday, December 10, 2019.

To view the full press release, visit http://nnw.fm/PGg3N

About Sigma Labs

Sigma Labs, Inc. (NASDAQ: SGLB) is a leading provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D(R) brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (CAI) solutions known as PrintRite3D(R) for 3D advanced manufacturing technologies. Sigma Labs’ advanced computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance mid-production, uniquely allowing errors to be corrected in real-time. For more information, please visit www.SigmaLabsInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, November 25th, 2019 Uncategorized Comments Off on $SGLB CEO to Present at the 12th Annual LD Micro Main Event

$GGBXF Significant Revenue Growth Driven by CBD Retail Expansion

Total first quarter fiscal 2020 revenues increased 77% quarter-over-quarter to $12.7 million

Well-positioned for upcoming holiday season with network of 193 CBD shops

COLUMBUS, OH, Nov. 25, 2019 – Green Growth Brands Inc. (GGB or the Company) (CSE: GGB) (OTCQB: GGBXF) today reported its results for the thirteen-week period ended September 28, 2019. Revenues for the period totaled $12.7M.

“As we approach the holiday shopping season, we are confident in our growth trajectory,” said Peter Horvath, CEO of Green Growth Brands. “We are proud of the topline growth we accomplished in Q1 and are extremely pleased with our current results, which are an indication of future growth. In fact, the four weeks of fiscal November, retail CBD sales were two-thirds of our total CBD sales reported in all of the thirteen weeks of first quarter fiscal 2020, which we are reporting today. This topline growth is reflective of our shift from investing in the foundation of our CBD business to focusing on its execution.

“In a very short-time we have grown a meaningful CBD footprint. We believe our products, network of shops, rapidly growing web business and wholesale relationships position us as a leader in the industry. In the coming quarters we look-forward to reporting similar trends and results for our MSO segment of the business. As we begin to reach scale our consumer and operations expertise will be clearly reflected, not only in the customer experiences we create and the loyalty we drive, but also in our financials as we work towards profitability.”

View Seventh Sense’s holiday campaign and holiday gifting assortment here.

GGB will host a conference call and audio webcast with Chief Executive Officer, Peter Horvath, Chief Operating Officer, Randy Whitaker, and Chief Financial Officer, Brian Logan, at 8:30 AM EST on Tuesday, November 26, 2019.

First Quarter Fiscal 2020 Highlights

  • Total revenue for the period was $12.7 million, a sequential increase of 77% over the prior quarter.
  • Pro forma revenues for the quarter were $15.3 million, reflecting a full quarter of revenue from The+Source Henderson, which was acquired on August 28, 2019.
  • MSO revenues for the quarter were $7.6M, a sequential increase of 38% over the prior quarter, primarily driven by the acquisition of The+Source Henderson.
  • The two Nevada-based The+Source dispensaries continue to generate annualized revenue of nearly $15,000 per selling square foot. A best-in-class figure in the cannabis industry and in retail overall.
  • CBD revenue for the quarter was $5.1 million, a sequential increase of 201% over the prior quarter. Growth was primarily driven by additional mall-based shop openings, growth in wholesale, and increased overall brand awareness. The Company expects to achieve over $10 million in CBD revenues in second quarter fiscal 2020.
  • The Company opened 81 mall-based CBD shops during the quarter, bringing the total number of shops open at quarter’s end to 139 in 34 states. The Company currently operates 193 shops.
  • The Company began filling American Eagle Outfitter’s white label order for ‘Mood’ during the quarter. Performance indications are strong, and the Company expects to continue partnering with American Eagle.
__________________________
1 eMarketer Retail, “Ecommerce trends and store sales for top retailers”

 

First Quarter Fiscal 2020 Financial Statements

The following tables contain financial information for the periods indicated. For full financial information, notes, and management commentary please refer to the MD&A and Financial Statements posted on Green Growth Brands’ Investor Relations site and SEDAR. All financial information is provided in United States dollars, unless otherwise indicated. “Adjusted EBITDA” is equal to net income (loss) before interest, taxes and depreciation and amortization, plus fair value adjustments on sale of inventory and on growth of biological assets, share-based compensation and payments, loss (gain) on equity investments, loss (gain) on foreign exchange, loss (gain) on short-term investments, transaction costs, listing fees and certain one-time non-operating expenses, as determined by management. Management believes this measure provides useful information as it is a commonly used measure in the capital markets and as it is a close proxy for repeatable cash generated by (used for) operations.

Unaudited Condensed Interim Consolidated Statements of Financial Position
As at September 28, 2019 and June 30, 2019
(Expressed in United States dollars)
September 28, 2019 June 30, 2019
Assets
Current Assets
Cash and cash equivalents $ 6,811,539 $ 10,256,008
Receivables 2,240,238 580,529
Prepaid expenses 3,452,367 5,142,618
Inventories 11,282,915 10,244,804
Biological assets 1,321,379 1,352,097
Notes receivable 48,103 47,739
Other receivables 2,969,527 3,006,760
Deferred lease charges 727,518
28,126,068 31,358,073
Non-current assets
Deposits and other assets 604,414 2,880,186
Deferred lease charges 2,606,940
Notes receivable 166,724 17,999,224
Property and equipment, net 29,052,104 18,761,723
Right-of-use assets 69,114,716
Intangible assets 101,991,179 39,925,984
Goodwill 58,398,385 36,253,417
 Total assets $ 287,453,590 $ 149,785,547
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 27,370,962 16,028,807
Taxes payable 514,535 282,593
Due to related parties 8,464,855 317,535
Notes payable 34,878,986 45,762,540
Lease liabilities 10,512,065
Embedded derivative liabilities 618,774 1,496,214
Convertible debentures 46,922,616 41,623,041
129,282,793 105,510,730
Non-current liabilities
Long term accrued liabilities 1,205,010 299,977
Lease liabilities 57,012,239
Embedded derivative liabilities 1,188,467
Convertible debentures 8,758,271
Deferred tax liability 6,985,048 1,437,324
75,149,035 1,737,301
Shareholders’ Equity
Share capital 182,371,023 119,881,374
Reserve for warrants 16,538,786 9,054,624
Reserve for share-based compensation 3,813,158 3,147,110
Accumulated deficit (122,566,395) (92,453,943)
Accumulated other comprehensive income 148,286 148,286
Total equity attributable to shareholders of Green Growth Brands Inc 80,304,858 39,777,451
Non-controlling interest 2,716,904 2,760,065
Total equity 83,021,762 42,537,516
 Total liabilities and equity $ 287,453,590 $ 149,785,547

 

Adjusted EBITDA
(Expressed in United States dollars)
September 28, September 30,
2019 2018
Net loss after listing fees before income taxes $ (29,886,676) $   (2,846,537)
Fair value adjustment on sale of inventory 906,919
Fair value adjustment on biological assets (507,284)
Stock based compensation 1,632,922
Depreciation and amortization 3,626,529
Pre-opening expenses 1,547,468
Non-operating expenses 6,264,165 156,102
Termination and severance 421,396
Writedown of developed technology 573,662
Other non-operating expenses 197,204
14,662,981 156,102
Adjusted EBITDA $ (15,223,695) $   (2,690,435)

 

Unaudited Condenseed Interim Consolidated Statements of Loss
For the 13 weeks ended September 28 2019 and for the three months ended September 30, 2018
(Expressed in United States dollars)
September 28,
2019
September 30,
2018
Sales
Revenue $ 12,701,958 $
Cost of goods sold 10,911,000
Gross profit before fair value adjustments 1,790,958
Fair value change in biological assets
included in inventory sold and other charges
906,919
Unrealized gain on changes in fair value of
biological assets
(507,284)
Gross profit 1,391,323
Operating Expenses
General and administrative 9,683,667 2,450,960
Sales and marketing 10,070,716
Share-based compensation 1,632,922
Depreciation and amortization 3,626,529
25,013,834 2,450,960
(23,622,511) (2,450,960)
Other expenses (income)
Gain in fair value of derivative liabilities (4,240,710)
Interest expense, net 3,761,477 217
Accretion on convertible debentures 1,409,583
Foreign exchange (gain) loss (488,387) 155,885
Transaction costs 5,822,202
Net loss before listing fees and income taxes (29,886,676) (2,607,062)
Listing fees 239,475
Net loss after listing fees (29,886,676) (2,846,537)
 Income taxes 356,609
Net loss after income taxes $ (30,243,285) $ (2,846,537)
Less:Non-controlling interest 43,161
Net Loss attributable to owners of the parent $ (30,200,124) $ (2,846,537)
Net loss per Common Share attributable to the parent
Basic and Diluted $ (0.15) $ (0.03)
Weighted average common shares 198,246,478 84,428,676

 

Unaudited Condensed Interim Consolidated Statement of Cashflow
For the 13 weeks ended September 28, 2019, and for the three months ended September 30, 2018
(Expressed in United States dollars)
September 28,
2019
September 30,
2018
Cashflow from Operating Activities
Net loss after income taxes for the period $ (30,243,285) $ (2,846,537)
Adjustments for:
Stock based compensation 1,632,922
Shares and warrants issued for services and fees 4,115,733 567,884
Depreciation and amortization 3,578,965
Writedown of developed software 409,022
Deferred tax expense (225,333)
Accretion expense 1,409,583
Gain in fair value of embedded derivative liabilities (4,240,710)
Net fair value adjustment on biological assets 399,635
Foreign exchange on translation (488,387)
Changes in working capital balances
Receivables (1,646,660)
Prepaid expenses 1,690,251
Other receivables 1,994,059 (185,874)
Inventories (27,538)
Biological assets (368,917)
Accounts payable and accrued liabilities 8,815,006 (787,634)
Taxes payable 231,942
(12,963,712) (3,252,161)
Cashflow from Investing Activities
Purchase of property and equipment (9,723,474)
Purchase of software (723,738)
Acquisition of business and assets, net of cash acquired (12,703,263)
Proceeds from sale of equity investment 11,792
Advances on acquisitions (32,347,500)
(23,138,683) (32,347,500)
Cashflow from Financing Activities
Cash received on warrants exercised 298,420
Proceeds from bought deal financing 36,513,665
Repayment of notes (15,485,000)
Principal payments of lease liabilities (1,589,689)
Proceeds from promissory notes 12,794,844
Proceeds from convertible debentures, net of issuance costs 66,061,829
32,532,240 66,061,829
Effect of exchange rates on cash 125,686
Increase in cash (3,444,469) 30,462,168
Cash, beginning of period 10,256,008 4,688,311
Cash, end of period $ 6,811,539 $ 35,150,479
Supplemental disclosure of cash flow information
Interest paid 445,232
Income taxes paid 350,000
Other non-cash investing and financing activities
Change in accrual for construction in progress 861,479
Acquisition of business for non-cash 47,107,913
Issuance of shares for underwriter fees on bought deal financing 2,080,494

 

Segmented statement of operations for the 14 weeks ended September 28, 2019 and three months ended September 30, 2018
(Expressed in United States dollars)
MSO CBD Head office Allocations Total
2019 2018 2019 2018 2019 2018 2019 2018 2019 2018
Sales
Revenue $ 7,555,102 $ $ 5,146,856 $ $ $ $ $ $ 12,701,958 $
Cost of goods sold 4,575,274 4,576,384 1,759,342 10,911,000
Gross profit before fair value adjustments 2,979,828 570,472 (1,759,342) 1,790,958
Fair value change in biological assets included in
inventory sold and other charges
906,919 906,919
Unrealized gain on changes in fair value of biological
assets
(507,284) (507,284)
Gross profit 2,580,193 570,472 (1,759,342) 1,391,323
Operating Expenses
General and administration 11,433,502 2,450,960 (1,749,835) 9,683,667 2,450,960
Sales and marketing 1,710,707 8,360,009 10,070,716
Stock based compensation 1,632,922 1,632,922
Depreciation and amortization 142,564 2,865,550 627,922 (9,507) 3,626,529
1,853,271 11,225,559 13,694,346 2,450,960 (1,759,342) 25,013,834 2,450,960
726,922 (10,655,087) (13,694,346) (2,450,960) (23,622,511) (2,450,960)
Non-operating expenses
Gain in fair value of derivative liabilities (4,240,710) (4,240,710)
Interest expense, net 21,712 1,117,964 2,621,801 217 3,761,477 217
Accretion expense 1,409,583 1,409,583
Foreign exchange (gain) loss (488,387) 155,885 (488,387) 155,885
Transaction costs 5,822,202 5,822,202
Net income (loss) before listing fees and income taxes 705,210 (11,773,051) (18,818,835) (2,607,062) (29,886,676) (2,607,062)
Listing fees 239,475 239,475
Net income (loss) after listing fees 705,210 (11,773,051) (18,818,835) (2,846,537) (29,886,676) (2,846,537)
 Income taxes 356,609 356,609
Net income (loss) after income taxes $ 348,601 $ $ (11,773,051) $ $ (18,818,835) $ (2,846,537) $ $ $ (30,243,285) $ (2,846,537)
Net income (loss) and comprehensive loss attributable to:
Owners of the parent 391,762 (11,773,051) (18,818,835) (2,846,537) (30,200,124) (2,846,537)
Non-controlling interest 43,161 43,161
348,601 (11,773,051) (18,818,835) (2,846,537) (30,243,285) (2,846,537)
Supplemental segemented information
Assets 173,818,672 101,694,365 11,940,553 67,702,122 287,453,590 67,702,122
Liabilities 32,201,594 79,177,273 93,052,961 66,925,655 204,431,828 66,925,655

 

Conference Call Information:

Conference ID: 54236169

Local Toronto Dial-in Number: (+1) 416 764 8609

Local Vancouver Dial-in Number: (+1) 778 383 7417

North American Toll-Free Number: (+1) 888 390 0605

The call and replay archive will be accessible on Green Growth Brands’ Investor Relations website.

About Green Growth Brands Inc.
Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and 8 Fold. The Company also has a licensing agreement with the Greg Norman™ Brand to develop a line of CBD-infused personal care products designed for active wellness. GGB is expanding its cannabis operations throughout the U.S., via dispensaries in Nevada, Massachusetts and Florida and the largest network of CBD shops in malls across the country and ShopSeventhSense.com. Learn more about the vision at  GreenGrowthBrands.com.

Cautionary Statements:

Certain information in this news release constitutes forward-looking statements under applicable securities law. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “intend”, “forecast” and similar expressions.   Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical and recreational marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the marijuana industry in the United States, income tax and regulatory matters; the ability of the Company to implement its business strategies; competition; currency and interest rate fluctuations and other risks, including those factors described under the heading “Risks Factors” in the Company’s Annual Information Form dated November 26, 2018 which is available on the Company’s issuer profile on SEDAR.

Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The forward-looking statements contained in this release, including, but not limited to, the Company’s ability to execute on its growth strategy, the Company’s plan to open new dispensaries in the remainder of the calendar year, the Company’s vision to become a multi-state operator with retail stores exceeding certain financial thresholds is made as of the date hereof and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

This announcement does not constitute an offer, invitation or recommendation to subscribe for or purchase any securities and neither this announcement nor anything contained in it shall form the basis of any contract or commitment. In particular, this announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States, or in any other jurisdiction in which such an offer would be illegal.

The securities referred to herein have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or under the securities laws of any state or other jurisdiction of the United States and may not be offered or sold, directly or indirectly, within the United States, unless the securities have been registered under the Securities Act or an exemption from the registration requirements of the Securities Act is available.

Monday, November 25th, 2019 Uncategorized Comments Off on $GGBXF Significant Revenue Growth Driven by CBD Retail Expansion

$TGODF Anticipates Increased Funding of up to $103 Million

November 25, 2019

  • TGOD’s ability to secure significant capital reflects its establishment in industry and strong governance foundation
  • The financing plan involved several components, including a sale-leaseback of Ancaster Energy Centre, a $40 million construction mortgage loan with an investment fund, and a $30 million convertible note.
  • Company plans for utilization of capital include completing construction of its various facilities and achieving national product distribution

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, recently signed agreements for increased funding amounting to up to $103 million. The company’s ability to secure capital at a time when cannabis companies are weathering the winds of a somewhat tempestuous market indicates investors’ faith in TGOD’s sound business practices, significant assets, and strong governance policies. TGOD is uniquely positioned in the industry as one of the only certified-organic cannabis companies, which when coupled with its recent funding acquisition shows its potential for strong growth in the cannabis sector.

The company’s diverse financing package consists of three pieces (http://cnw.fm/I0vz5), which include “a definitive agreement for a sale-leaseback of the Ancaster Energy Centre, a construction mortgage loan term sheet, and a convertible equity note term sheet.” The agreement for the Ancaster Energy Centre is non-dilutive, denotes proceeds of $23 million, and carries a 10-year term, after which TGOD is able to repurchase the center for $1.

A term sheet with an investment fund for a $40 million construction mortgage loan has also been signed, secured on the facilities at Ancaster and Valleyfield. With this term, $15 million will be payable on closing, with an additional $25 million advance available to TGOD once certain operational milestones are achieved later in 2020. The last segment of its financing involves TGOD’s entrance into a term sheet with an investment fund for a $30 million note with a 5% coupon, which is convertible into common shares of TGOD. These terms indicate that TGOD would receive $10 million upon closing with $20 million immediately placed into escrow to be released as the note is converted into common shares. Closing of the two non-binding term sheets is subject to various conditions, including entering into legally binding documentation, satisfactory due diligence and the receipt of required regulatory approvals. The company expects to close these transactions by the end of Q4, 2019, but there can be no assurance that the transactions close on that time frame or at all.

“Our ability to raise capital, despite recent headwinds affecting the entire sector, is a clear show of confidence from our financial partners,” TGOD CEO Brian Athaide stated in a news release. “It is reflective of the value of our significant assets, the trust investors are putting into TGOD’s strong corporate governance, transparency and accountability, and the opportunity for the company’s unique positioning to quickly capture and grow the organic segment.”

The Green Organic Dutchman, one of the few certified-organic licensed producers in Canada, has garnered industry attention because of its ability to cultivate premium product at competitive costs, due in large part to its industry partnerships, passion for product excellence, and sound governance principles. The company has accrued a significant following among cannabis enthusiasts and was recently described as one of the best licensed Canadian cannabis producers (http://cnw.fm/w7vSJ).

TGOD intends to use its increased capital from the financings to continue executing its plan for “rapid yet disciplined expansion,” focusing concretely on near-term profitability. In this vein, raised capital will be used to accomplish the following:

  • Complete construction of the processing facility at Ancaster
  • Complete construction of six zones in the Valleyfield hybrid greenhouse and enclose the balance of the facility with the ability to quickly expand production as the market develops.
  • Provide adequate cash for working capital needs to bridge until the company anticipates generating positive operational cash flow
  • Achieve national distribution of TGOD products in early 2020

The company continues to work toward its mission of nurturing a community focused on a sustainable way of life. With significant funding to power its multifaceted growth strategy, TGOD is well-positioned for continued success in the organic-cannabis sector.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://cnw.fm/TGODF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, November 25th, 2019 Uncategorized Comments Off on $TGODF Anticipates Increased Funding of up to $103 Million

$SRAX Reports Promising Q3 Results, Positions Itself for Global Adoption

November 25, 2019

  • SRAX reports Q3 results, shows significant sales increase
  • Company continues to make platforms more accessible internationally
  • SRAX added partners, including nonprofit associations that give BIGtoken users opportunity to donate earnings to worthy causes

SRAX Inc. (NASDAQ: SRAX) is a digital marketing and data management technology company. Through SRAX’s BIGtoken platform, consumers have the opportunity to both own and monetize their data.

On September 30, 2019, SRAX reported significant Q3 results. On the financial side, the company saw a vertical sales increase of 17% along with a net income of $1.4 million (http://nnw.fm/An1zq). These gains arose out of a critical quarter for the company that included multiple milestones, including a full integration for international users and the first steps in the process of offering BIGtoken in multiple languages.

Christopher Miglino spoke about the traction that the company’s platforms are gaining, noting that “sales from existing platforms grew 11% and 17%, for Q3 2019 compared to Q2 2019 and Q3 2018, respectively, and are already benefiting from advances in BIGtoken.”

Currently a significant backlash is taking place over the privacy of data between consumers and big social media platforms such as Facebook, Twitter, Snapchat and LinkedIn. SRAX is helping consumers take control over their personal data; its BIGtoken website notes that “as a consumer, you are a commodity that generated billions in revenue last year — and none of it went to you” (http://nnw.fm/RQSp0).

Consumers can use the BIGtoken app to see how much they have earned from marketers. In addition, using the app, consumers have several opportunities to make money from data that is already being taken for free from social media platforms. For instance, BIGtoken platform users can earn points through surveys and location check-ins as well as earn rewards through purchases. Consumers can redeem their points for cash or gift cards, but the app also provides other choices. SRAX has partnered with a number of nonprofits, including the American Heart Association and HealthCorps, to give BIGtoken users the option to donate their earnings to worthy causes.

The BIGtoken app continues to grow in popularity as the company enhances its features. Currently more than 16 million SRAX users exist worldwide, and this number continues to grow. The company recently formed strategic partnerships in India and the Philippines to help increase the number of users.

Based in Los Angeles, SRAX is a digital marketing and data management technology company focused on building the largest and most valuable opted-in data set in the world. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. SRAX delivers a competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Monday, November 25th, 2019 Uncategorized Comments Off on $SRAX Reports Promising Q3 Results, Positions Itself for Global Adoption

$OGI Announces Q4 and 2019 Fiscal Year Results

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its results for the fourth quarter and fiscal year ended August 31, 2019 (“Q4” or “Q4 2019”). Among the highlights, Organigram reported a 547% growth in 2019 net revenue to $80.4 million from $12.4 million in 2018, and a 575% increase in 2019 gross margin, before fair value changes to biological assets and inventory, to $37.9 million or 47% of net revenue from $5.6 million or 45% of net revenue in 2018. “Our 2019 results reflected a successful year for Organigram. Not only did we report strong top-line growth and establish an enviable national market share position in Canada, we generated positive adjusted EBITDA – one of the key measures we use to evaluate our performance,” Organigram Chief Executive Officer Greg Engel said in the news release. “In 2019, we increased staffing and capacity to meet forecasted demand and maintain inventory in the market. Industry structural issues have challenged supply and demand dynamics in the short-term but we believe the growth opportunity in the Canadian cannabis market remains intact.”

To view the full press release, visit http://cnw.fm/GS2eh

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select Market and a Toronto Stock Exchange (“TSX”) listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by Health Canada under the Cannabis Act (Canada) and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://cnw.fm/OGRMF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Monday, November 25th, 2019 Uncategorized Comments Off on $OGI Announces Q4 and 2019 Fiscal Year Results

$POAI Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

MINNEAPOLIS, Nov. 25, 2019 — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that based on a notification letter (the “Notification Letter on Compliance”) recently received from the Listing Qualifications Department of the Nasdaq Stock Market Inc. (the “Nasdaq”), the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the “Minimum Bid Price Requirement”).

On November 16, 2018, the Company received a notification letter from the Nasdaq (the “Notification Letter on Deficiency”) indicating that the closing bid price per share had been below $1.00 for a period of 30 Consecutive business days and that the Company did not meet the Minimum Price Bid Requirement. According to the Notification Letter on Deficiency, if at any time during the Compliance Period, the closing bid price for the Company is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed.

According to the Notification Letter on Compliance, the staff of Nasdaq has determined that for the 10 consecutive business days, beginning from October 29, 2019 to November 11, 2019, the closing bid price Of the Company’s common stock has been at $1.00 per share or greater, and the Company has regained compliance with the Minimum Bid Price Requirement, and the matter is now closed.

About Predictive Oncology Inc.

Predictive Oncology (Nasdaq: POAI) operates through five segments (Domestic, International, Clinical, CRO and DCHIP), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™, patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform (D- CHIP) to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s TumorGenesis subsidiary is developing a new rapid approach to growing tumors in the laboratory, which essentially “fools” cancer cells into thinking they are still growing inside a patient. Its proprietary Oncology Discovery Technology Platform kits will assist researchers and clinicians to identify which cancer cells bind to specific biomarkers. Once the biomarkers are identified they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and help categorize an individual patient’s heterogeneous tumor samples to enable the development of patient specific treatment options. Helomics and TumorGenesis are focused on ovarian cancer. Predictive Oncology’s Skyline Medical division markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.predictive-oncology.com.

Forward-looking Statements

Certain of the matters discussed in the press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include (i) risks related to the recent merger with Helomics, including the fact that the combined company will not be able to continue operating without additional financing; possible failure to realize anticipated benefits of the merger; costs associated with the merger may be higher than expected; the merger may result in disruption of the Company’s and Helomics’ existing businesses, distraction of management and diversion of resources; and the market price of the Company’s common stock may decline as a result of the merger; (ii) risks related to our partnerships with other companies, including the need to negotiate the definitive agreements; possible failure to realize anticipated benefits of these partnerships; and costs of providing funding to our partner companies, which may never be repaid or provide anticipated returns; and (iii) other risks and uncertainties relating to the Company that include, among other things, current negative operating cash flows and a need for additional funding to finance our operating plan; the terms of any further financing, which may be highly dilutive and may include onerous terms; unexpected costs and operating deficits, and lower than expected sales and revenues; sales cycles that can be longer than expected, resulting in delays in projected sales or failure to make such sales; uncertain willingness and ability of customers to adopt new technologies and other factors that may affect further market acceptance, if our product is not accepted by our potential customers, it is unlikely that we will ever become profitable; adverse economic conditions; adverse results of any legal proceedings; the volatility of our operating results and financial condition; inability to attract or retain qualified senior management personnel, including sales and marketing personnel; our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; Predictive’s ability to implement its long range business plan for various applications of its technology; Predictive’s ability to enter into agreements with any necessary marketing and/or distribution partners and with any strategic or joint venture partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of Predictive’s technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company’s reports filed with the SEC, which are available for review at www.sec.gov. This is not a solicitation to buy or sell securities and does not purport to be an analysis of Predictive’s financial position. See Predictive’s most recent Annual Report on Form 10-K, and subsequent reports and other filings at www.sec.gov.

Contact:
Charles Moskowitz
info@MoneyInfo-LLC.com
339-201-7457

Monday, November 25th, 2019 Uncategorized Comments Off on $POAI Has Regained Compliance with Nasdaq’s Minimum Bid Price Requirement

$CNPOF $RIV.V CEO Interview, Investor Ideas Potcasts, Cannabis News and Stocks on the Move

Delta, Kelowna, BC – November 25, 2019 – www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM – cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2019/112519-StocksToWatch-RIV.mp3

 

Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Canopy Rivers (TSX: $RIV.V) (OTC: $CNPOF) CEO Interview

November 25, 2019

SHARE PODCAST:

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast Investorideas interviews Narbe Alexandrian, President and CEO of Canopy Rivers Inc. (TSX:RIV) (OTC: CNPOF), where he discusses the company’s most recent news and financials as well as the industry as a whole.

When asked about what has been developing in the Canopy Rivers portfolio since our previous interview, Alexandrian went on to say, “there’s a lot that’s taken place for Canopy Rivers and our portfolio of companies over the last little while. We have a portfolio company in the data intelligence sector, Headset, which recently launched a data intelligence tool for retailers to understand what their sales metrics are as well as to compare metrics with the overall marketplace. Headset has also launched into Canada with Alberta being the first province. Our multi-state operator, TerrAscend Corporation, appointed Jason Ackerman to its board of Directors. Jason is a founder and former CEO of online grocer Fresh Direct and was also named executive chairman of the company and is going to be overseeing the day to day operations of the U.S. segment of TerrAscend. James E. Wagner Cultivation raised a sizeable loan from Trichome Financial Corporation, using it to expand its flagship facility in Kitchener, Ontario and continue with its cultivation. Subsequently, JWC announced two major announcements to position it as a leading producer and supplier of premium cannabis products. First it entered into a supply and manufacturing agreement with Cannacure Corporation, for the filling of vape cartridges for the Canadian market, as well as it entered into a brokerage agreement with Kindred. Kindred is something that Canopy Rivers has been working on for quite some time. Kindred is the cannabis distribution platform for Breakthrough Beverages, and for those who don’t know, Breakthrough Beverages is the top one or two largest liquor distributor in North America and they do work with Diageo or Gala Wines, and they;ve taken a step into the cannabis industry to use the power of distribution and understanding of regulated markets to create a distribution platform for Cannabis companies within the Canadian market. We’re really excited about our strategic partnership and about lending them into our portfolio of companies.”

Alexandrian continued to discuss how this partnership with Kindred would add value to the Canopy Rivers portfolio of companies, especially with regards to Cannabis 2.0, saying, “the problem we have within the Canadian industry, or just in general within the industry, is lack of distribution. You have a ton of demand in every single geography that’s looking to legalize and you have a number of producers as well but just the distribution points of retail just aren’t there. I like to use the anecdote of Coke and Pepsi who aren’t successful because they spend hundreds of millions of dollars on advertising; they’re successful because they have distribution. Any store, restaurant, quick service or fast food chain that you walk into, there’s typically a Coke and Pepsi machine there or some type of vending machine or fridge you can get product off of. That’s distribution 101. On the cannabis side, we’re just seeing distribution start to form, especially in Canada, but in some U.S. States as well that are starting to legalize, where currently its really hard to get product and your fighting with the illicit market, overtime distribution becomes more prominent. To get to multiple points you can develop everything in house or you can go out and find one of the distributors in the market. Our thesis at Canopy Rivers is that vertical integration doesn’t work. So in our perspective there’s going to be a leader that’s a pure play distribution platform, and we thought that the team and vision that Breakthrough Beverages had in creating Kindred were really top notch and that this was going to be a company that was going to usher in a new form of distribution within the Cannabis sector.”

Alexandrian went on to discuss the industry in general in both the U.S. and Canada as well as what investors can look forward to from Canopy Rivers.

To find out more information regarding Canopy Rivers visit their website here.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the

Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com – News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411

Monday, November 25th, 2019 Uncategorized Comments Off on $CNPOF $RIV.V CEO Interview, Investor Ideas Potcasts, Cannabis News and Stocks on the Move

$YGYI Florida Poll Reveals Overwhelming Support for Cannabidiol Research

November 25, 2019

Cannabidiol (CBD), the cannabis extract that has been referred to as a ‘miracle drug’ by some has been all the rage over the past few years. Said to be effective against a variety of medical conditions, the compound has been subject to great interest.

The 2018 Hemp Farming Act catalyzed the sector’s growth, allowing farmers to grow industrial hemp under state programs and inevitably, leading to an influx of suppliers, each looking to cash in on the insanely popular cash crop.

The industry’s growth has been so fast that it has outpaced regulators, leaving them scrambling to create some sort of order in a sector flooded with thousands of untested products. Results from a recent survey show that a large majority of CBD consumers wish the industry had a more comprehensive regulatory structure.

The poll by the advocacy group National Consumers League found out that 86% of Floridians think CBD products “should be safe, backed by proven science and work as advertised.”

Patricia Kelmar, with the National Consumers League, says that the poll is evidence that people are looking beyond conventional medicines, but more research has to be done first. “CBD has the potential to provide therapy and give us some relief, but we have to make sure that the science is behind it.”

In the wake of the 2018 Farm Bill, tons of firms joined the cannabidiol fray, each selling products promising untold medical benefits. This is despite warnings from the FDA that marketing and selling CBD products as dietary supplements is illegal. In the past weeks, the organization has issued further warnings to companies making unsubstantiated claims about the benefits of their products, including a Florida company.

The FDA and the Federal Trade Commission (FTC) sent Florida-based company Rooted Apothecary a warning letter for claiming that its CBD products could treat the symptoms of conditions such as ADHD, Parkinson’s disease, and autism among others on its website and social media accounts.

Ned Sharpless, Acting Commissioner of the FDA at the time, said that the organization is working to protect Americans from companies marketing products with unsubstantiated claims that they prevent, diagnose, treat or cure a number of diseases or conditions.

“We’ve sent numerous warning letters that focus on matters of significant public health concern to CBD companies, and these actions should send a message to the broader market about complying with FDA requirements. As we examine potential regulatory pathways for the lawful marketing of cannabis products, protecting and promoting public health-based decision making remains our top priority.”

Amy Abernethy, FDA Principal Deputy Commissioner, says that they recognize that there has been significant public interest in cannabis and cannabis-derived products. She adds that “we are committed to advancing our regulation of these products through an approach that, in line with our mission, prioritizes public health, fosters innovation and promotes consumer confidence.”

Experts recommend that CBD industry actors, including companies like Youngevity International Inc. (NASDAQ: YGYI) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), take the lead in furthering research so that the concerns of the public can be addressed.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Monday, November 25th, 2019 Uncategorized Comments Off on $YGYI Florida Poll Reveals Overwhelming Support for Cannabidiol Research

$CNPOF $RIV.V Ohio Farmers Fear Draft Hemp Rules Could Lock Them Out

November 22, 2019

The hemp industry, it seems, is on a wild roller coaster that won’t seem to stop. For starters, the crop has for decades had a taboo aspect to it because of its relation to the infamous marijuana. Still, it has numerous other non-intoxicating uses, and in 2018, Congress passed the Farm Bill, effectively legalizing the cultivation of industrial hemp. The sector quickly grew carried by demand for the increasingly popular hemp extract cannabidiol (CBD), and in just one short year, the industry was flooded with thousands of unregulated CBD products.

After continued calls for the United States Department of Agriculture (USDA) to provide a regulatory structure for the sector, the agency finally released its interim final rule on hemp. Under the new rule, any State or Indian Tribe that wishes to have a hemp program will have to submit a state plan to the USDA for evaluation. As states write up their hemp regulations, small hemp farmers in Ohio are feeling like they got the short end of the stick after learning about the new costs and planting requirements.

Under the Ohio Department of Agriculture’s proposed rules, hemp farmers in the state must use at least a quarter acre and grow at least 1000 plants. Application and license fees will total hundreds of dollars. David Miran, Executive Director of the department’s hemp program, says the rules were devised after a review of hemp programs in other states and assessing what worked and didn’t work for them.

However, small farmers interested in hemp fear the new stringent requirements might lock them out of a very lucrative cash crop. Andy Huop grows organic vegetables on two acres in Groveport, and he is always on the lookout for high value crops to grow on small plots. According to him, the acreage and planting requirements are a high barrier to entry. “We would love to get our foot in the door and start learning about how to produce the crop successfully,” he says.

Miran, on the other hand, says the state wants to only grow hemp for commercial purposes. “If too many people grow hemp on small patches in their backyards, police would have difficulty differentiating it from illegal marijuana as the plants look similar,” he says. “Restricting the crop to larger operations eases that burden.”

He says that the proposed rules provide wiggle room for farmers with slightly less than a quarter of an acre to grow hemp on, or those who plant slightly fewer than 1000 plants. “The variance is dictated by logic and reason,” he says. Farmers will have to pay a $500 dollar application fee, and those who want to grow hemp in more than one location will have to pay the fee for each site.

Jen Lunch, President of the Ohio Hemp Association, says that the new rules may be restrictive, but they won’t break the industry. “But overall,” she says, “the state wrote a solid set of rules.” The rules are expected to be finalized in January.

It is a widely held belief that hemp industry players like Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) and Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) prefer an arrangement that favors everybody, including small farmers.

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.

Friday, November 22nd, 2019 Uncategorized Comments Off on $CNPOF $RIV.V Ohio Farmers Fear Draft Hemp Rules Could Lock Them Out

$LXRP NY Activists Vow to Improve Stalled CBD and Hemp Bill

November 22, 2019

The 2018 Hemp Farming Act was a godsend for the hemp industry. The legislation classified cannabis with less than 0.3 percent THC as hemp and removed it from its list of controlled substances. Dubbed by some as a catalyst for explosive growth, the bill gave farmers in all 50 states leeway to grow the versatile cash crop under regulation.

Six months later in June 2019, the New York Assembly passed the state’s own Hemp Extract Bill. The bill would have allowed licensed retailers to add up to 20mg of CBD per twelve ounces beverage. However, several months later, the bill still languishes on Governor Andrew Cuomo’s desk, awaiting his approval.

As the New York hemp industry remains in a state of uncertainty, a group of industry insiders is looking to have the bill approved as soon as possible. Jonathan Miller, a lawyer for the U.S. Hemp Roundtable says Governor Cuomo is expected to issue a ‘friendly veto’ of the bill, which will allow it to be reintroduced during the budget process next year. “He likes the bill but is expected to veto it so we can improve it for the next session.”

However, without concrete regulations, the industry quickly filled up with sellers whose products promise untold benefits. A lot of the unregulated products contain different levels of cannabinoids promised on the labels and other contaminants. To ensure consumer safety, the New York State Department of Health and Agriculture stepped in, but in the process, sellers maintaining high product quality have also been affected.

At the moment, CBD can only be sold in the State as a dietary supplement. According to Joy Beckerman, President of the Hemp Industries Association, the organization would like to see three key issues addressed when the hemp bill is reintroduced. First, looser licensing requirements for manufacturers and sellers, capped fees for growers and producers, and lastly, to open up the New York hemp market to growers and processors from other states.

She says that what the organization desires is “better protection for small New York farms and businesses to be able to enter the hemp economy and take advantage of these new opportunities.” According to Karlan Castetter, a New York hemp producer and the CEO of Castetter Sustainability Group, developing a transparent and consistent supply chain and listing the region where the plants are grown is important. “We don’t want imported hemp that’s full of contaminants. All that it takes is a couple of bad products.”

Castetter says that although the June 2019 bill was a little restrictive, it was a step toward ensuring the New York hemp sector isn’t left behind by other states. “We don’t have three or four years. This market is moving very quickly, so we need to get ahead of that now.”

Experts think CBD players, such as Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Neutra Corp. (OTC: NTRR) are happy that new life is going to be breathed into New York State’s CBD law.

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Friday, November 22nd, 2019 Uncategorized Comments Off on $LXRP NY Activists Vow to Improve Stalled CBD and Hemp Bill

$GNPX Announces $1.26M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company, on Wednesday announced a registered direct offering of 3,167,986 shares of its common stock at a price of $0.40 each, for gross proceeds of about $1.26 million prior to deduction of commissions and offering expenses. In a concurrent private placement, Genprex agreed to issue unregistered warrants to purchase up to 3,167,986 shares to the investors in the registered direct offering. The warrants, which have an exercise price of $0.46 per share, will be exercisable six months from the issuance date and will expire after five years. The warrants will be exercisable for 100% of shares purchased by each investor in the registered direct offering. Additionally, Genprex agreed to decrease the exercise price of 2,283,740 warrants held by the purchasers in the registered direct offering to $0.46, which will be exercisable six months from the closing of the offering and the expiration date will be extended to January 27, 2024. Closing is anticipated to take place on or around November 25, 2019, subject to the completion of customary closing conditions. Genprex plans to use the net proceeds of the offering for working capital and general corporate purposes.

To view the full press release, visit http://nnw.fm/1If9r

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform. Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Thursday, November 21st, 2019 Uncategorized Comments Off on $GNPX Announces $1.26M Registered Direct Offering

$LXRP Enhanced Technology Shows Rapid Onset of Action in Under 10 Minutes

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its development of additional enhancements for its industry-leading DehydraTECH(TM) platform that delivers THC onset of action in less than 10 minutes in human pilot testing. According to the update, volunteers in recent human subjective pilot tests reported onset in less than 10 minutes from edibles formulated with this latest DehydraTECH innovation. This enhanced version of the delivery platform shows onset that is roughly twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations.

To view the full press release, visit http://cnw.fm/G4mY9

About Lexaria Bioscience Corp.

Lexaria Bioscience Corp. is a global innovator in drug-delivery platforms. Its patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXRP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Thursday, November 21st, 2019 Uncategorized Comments Off on $LXRP Enhanced Technology Shows Rapid Onset of Action in Under 10 Minutes

$SGLB Highlighted in Evaluation of Disruptive Manufacturing Technologies

NEW YORK, Nov. 21, 2019  — via NetworkNewsAudio – Sigma Labs Inc. (NASDAQ: SGLB) announces the availability of a broadcast titled, “Profiting from the Fourth Industrial Revolution.”

To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/5Px4W

To read the full editorial, visit: http://nnw.fm/1WhBz

Heralded as the fourth industrial revolution, 3D printing is about to transform the $12 trillion global manufacturing sector. Sigma Labs Inc. (NASDAQ: SGLB) is on the verge of unleashing the dynamic forces of additive metal manufacturing that have been restrained. Long heralded as the fourth industrial revolution, 3D metal printing and its full potential have been stalled due to the high cost and complexities of end-product inspection and quality control. Sigma Labs’ PrintRite3D(R) software represents a seismic shift in the quality-assurance process in the manufacture of 3D-printed metal components, and the entire sector is poised for extraordinary growth.

To move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality-control problems must be identified in real-time. The anomaly, along with the solution, must then be communicated to the machine operator to immediately implement repairs. 3D printing will only truly surpass conventional manufacturing techniques when the additive manufacturing industry moves from post-process quality control to in-process quality assurance. Sigma Labs believes it has the solution.

About Sigma Labs

Sigma Labs Inc. (NASDAQ: SGLB) is an emerging provider of quality assurance software to the commercial 3D printing industry under the PrintRite3D® brand. Founded in 2010, Sigma is a software company that specializes in the development and commercialization of real-time computer aided inspection (“CAI”) solutions known as PrintRite3D for 3D advanced-manufacturing technologies. Sigma Labs’ advanced, computer-aided software product revolutionizes commercial additive manufacturing, enabling nondestructive quality assurance mid-production, uniquely allowing errors to be corrected in real time. For more information, please visit www.SigmaLabsInc.com.

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Thursday, November 21st, 2019 Uncategorized Comments Off on $SGLB Highlighted in Evaluation of Disruptive Manufacturing Technologies